---
schema_version: "secwatch.filing_event.v1"
accession: "0000719135-24-000003"
form_type: "8-K"
ticker: "APYX"
cik: "0000719135"
company_name: "Apyx Medical Corp"
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T02:42:12.232996+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Apyx Medical reports preliminary Q4 rev $14.2-14.6M (+13-16% YoY); FY rev $51.9-52.3M (+17-18%)

## Summary
- Total Q4 revenue $14.2-14.6M, growth 13-16% YoY; Advanced Energy $11.9-12.3M (+12-16%).
- Full year total revenue $51.9-52.3M (+17-18%); Advanced Energy $43.1-43.5M (+17-18%); OEM $8.8M (+14%).
- CEO says sales softer than expected due to challenging macro environment in cosmetic surgery market; slower new customer adoption.
- Company plans to release full Q4 and FY 2023 results in March 2024.

## SEC filing metadata
- accession: 0000719135-24-000003
- form_type: 8-K
- ticker: APYX
- cik: 0000719135
- company_name: Apyx Medical Corp
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/719135/000071913524000003/0000719135-24-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/719135/000071913524000003/apyx-20240108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000719135-24-000003
- JSON: https://secwatch.observer/filing/0000719135-24-000003.json
- Plain text: https://secwatch.observer/filing/0000719135-24-000003.txt

## Key facts
- Earnings Releases
  Apyx Medical Corp reported the fourth quarter ended December 31, 2023 results: revenue $14.2 to $14.6 million.
  - Period: the fourth quarter ended December 31, 2023
  - Revenue: $14.2 to $14.6 million
  - Result: preliminary results
  source text: Total revenue in a range of $14.2 to $14.6 million, representing growth of 13% to 16% year-over-year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/719135/000071913524000003/0000719135-24-000003-index.htm
- Earnings Releases
  Apyx Medical Corp reported the year ended December 31, 2023 results: revenue $51.9 to $52.3 million.
  - Period: the year ended December 31, 2023
  - Revenue: $51.9 to $52.3 million
  - Result: preliminary results
  source text: Total revenue in a range of $51.9 to $52.3 million, representing growth of 17% to 18% year-over-year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/719135/000071913524000003/0000719135-24-000003-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.